CellectisCLLS

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Andre Choulika

$200.9M

Market Cap • 12/07/2024

2000

(há 24 anos)
Fundação

2015

(9 years ago)
IPO

NASDAQ

Listagem
Flag of FR

Paris

236

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CLLSSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

9%

1 dia

09/07/2024

2%

1 semana

05/07/2024

-14%

1 mês

12/06/2024

-9%

1 ano

12/07/2023

-87%

5 anos

12/07/2019

10 anos

Histórico